10-Q Filing

ELANCO ANIMAL HEALTH INC CIK: 1739104 Q3 2019

Filing Information

Form Type	10-Q
Accession Number	`0001739104-19-000016`
Period End Date	20190930
Filing Date	20191108
Fiscal Year	2019
Fiscal Period	Q3
XBRL Instance	elan-20190930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 68 Cash Flow Statement 60 Stockholders Equity 46 Comprehensive Income 28

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$8.40M	USD	Point-in-time
Accounts receivable, net of allowances	`AllowanceForDoubtfulAccountsReceivableCurrent`	$6.30M	USD	Point-in-time
Property and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$878.60M	USD	Point-in-time
Property and equipment, net of accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$909.30M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$474.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$300.00M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$309.20M	USD	Point-in-time
Common stock authorized (in shares)	`CommonStockSharesAuthorized`	5.00B	shares	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	365.64M	shares	Point-in-time
Accounts receivable, net of allowances of $6.3 (2019) and $8.4 (2018)	`AccountsReceivableNetCurrent`	$758.30M	USD	Point-in-time
Common stock issued (in shares)	`CommonStockSharesIssued`	373.00M	shares	Point-in-time
Accounts receivable, net of allowances of $6.3 (2019) and $8.4 (2018)	`AccountsReceivableNetCurrent`	$651.80M	USD	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	365.64M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$57.60M	USD	Point-in-time
Common stock outstanding (in shares)	`CommonStockSharesOutstanding`	373.00M	shares	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$65.10M	USD	Point-in-time
Inventories (Note 8)	`InventoryNet`	$1.07B	USD	Point-in-time
Inventories (Note 8)	`InventoryNet`	$1.00B	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$113.90M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$98.00M	USD	Point-in-time
Restricted cash (Note 17)	`RestrictedCashCurrent`	$634.90M	USD	Point-in-time
Restricted cash (Note 17)	`RestrictedCashCurrent`	$11.10M	USD	Point-in-time
Restricted cash (Note 17)	`RestrictedCashCurrent`	$202.70M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.50B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.31B	USD	Point-in-time
Goodwill	`Goodwill`	$2.96B	USD	Point-in-time
Goodwill	`Goodwill`	$2.95B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.44B	USD	Point-in-time
Other intangibles, net	`IntangibleAssetsNetExcludingGoodwill`	$2.45B	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$118.40M	USD	Point-in-time
Other noncurrent assets	`OtherAssetsNoncurrent`	$220.20M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $909.3 (2019) and $878.6 (2018)	`PropertyPlantAndEquipmentNet`	$911.70M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $909.3 (2019) and $878.6 (2018)	`PropertyPlantAndEquipmentNet`	$922.40M	USD	Point-in-time
Total assets	`Assets`	$8.82B	USD	Point-in-time
Total assets	`Assets`	$8.96B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$206.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$205.20M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$98.90M	USD	Point-in-time
Employee compensation	`EmployeeRelatedLiabilitiesCurrent`	$88.80M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$182.20M	USD	Point-in-time
Sales rebates and discounts	`ContractWithCustomerLiabilityCurrent`	$169.90M	USD	Point-in-time
Current portion of long-term debt (Note 9)	`LongTermDebtCurrent`	$29.00M	USD	Point-in-time
Current portion of long-term debt (Note 9)	`LongTermDebtCurrent`	$24.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$181.50M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$199.00M	USD	Point-in-time
Payable to Lilly (Note 17)	`DueToRelatedPartiesNoncurrent`	$268.70M	USD	Point-in-time
Payable to Lilly (Note 17)	`DueToRelatedPartiesNoncurrent`	$58.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$970.70M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$741.50M	USD	Point-in-time
Long-term debt (Note 9)	`LongTermDebtNoncurrent`	$2.34B	USD	Point-in-time
Long-term debt (Note 9)	`LongTermDebtNoncurrent`	$2.44B	USD	Point-in-time
Accrued retirement benefits (Note 15)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$109.10M	USD	Point-in-time
Accrued retirement benefits (Note 15)	`PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent`	$81.40M	USD	Point-in-time
Deferred taxes (Note 12)	`DeferredIncomeTaxLiabilitiesNet`	$81.10M	USD	Point-in-time
Deferred taxes (Note 12)	`DeferredIncomeTaxLiabilitiesNet`	$114.60M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$121.50M	USD	Point-in-time
Other noncurrent liabilities	`OtherLiabilitiesNoncurrent`	$96.40M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.34B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.76B	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized, 372,999,206 and 365,643,911 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	-	USD	Point-in-time
Common stock, no par value, 5,000,000,000 shares authorized, 372,999,206 and 365,643,911 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.65B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$5.40B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$93.80M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$16.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-252.50M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-222.20M	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.14B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.27B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.58B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.49B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.78B	USD	Point-in-time
Total equity	`StockholdersEquity`	$5.20B	USD	Point-in-time
Total equity	`StockholdersEquity`	$7.90B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.96B	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$8.82B	USD	Point-in-time

Income Statement 68 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$761.10M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.28B	USD	3 Qtrs
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$771.30M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$2.27B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$369.80M	USD	1 Quarter
Cost of sales	`CostOfGoodsAndServicesSold`	$1.06B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$1.16B	USD	3 Qtrs
Cost of sales	`CostOfGoodsAndServicesSold`	$360.40M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$202.80M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$58.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$69.90M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$185.50M	USD	3 Qtrs
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$179.00M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$192.30M	USD	1 Quarter
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$550.10M	USD	3 Qtrs
Marketing, selling and administrative	`SellingGeneralAndAdministrativeExpense`	$574.30M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$48.70M	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$149.00M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$147.30M	USD	3 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$50.70M	USD	1 Quarter
Asset impairment, restructuring and other special charges (Note 7)	`RestructuringSettlementAndImpairmentProvisions`	$82.80M	USD	3 Qtrs
Asset impairment, restructuring and other special charges (Note 7)	`RestructuringSettlementAndImpairmentProvisions`	$12.40M	USD	1 Quarter
Asset impairment, restructuring and other special charges (Note 7)	`RestructuringSettlementAndImpairmentProvisions`	$133.90M	USD	3 Qtrs
Asset impairment, restructuring and other special charges (Note 7)	`RestructuringSettlementAndImpairmentProvisions`	$77.20M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$8.60M	USD	3 Qtrs
Interest expense, net of capitalized interest	`InterestExpense`	$60.20M	USD	3 Qtrs
Interest expense, net of capitalized interest	`InterestExpense`	$8.60M	USD	1 Quarter
Interest expense, net of capitalized interest	`InterestExpense`	$18.70M	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-4.90M	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-21.10M	USD	3 Qtrs
Othernet, expense	`NonoperatingIncomeExpense`	$-14.60M	USD	1 Quarter
Othernet, expense	`NonoperatingIncomeExpense`	$-15.60M	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$2.15B	USD	3 Qtrs
Costs, expenses and other	`CostsAndExpenses`	$682.30M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$783.80M	USD	1 Quarter
Costs, expenses and other	`CostsAndExpenses`	$2.20B	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$82.50M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-12.50M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$78.80M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$116.30M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$5.10M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$18.60M	USD	1 Quarter
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$46.20M	USD	3 Qtrs
Income tax (benefit) expense	`IncomeTaxExpenseBenefit`	$-22.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$10.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.40M	USD	3 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$0.20	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$0.03	USD	1 Quarter
Basic (usd per share)	`EarningsPerShareBasic`	$0.21	USD	3 Qtrs
Basic (usd per share)	`EarningsPerShareBasic`	$0.24	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.20	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.21	USD	3 Qtrs
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.03	USD	1 Quarter
Diluted (usd per share)	`EarningsPerShareDiluted`	$0.24	USD	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	371.60M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	296.00M	shares	3 Qtrs
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	301.20M	shares	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	367.70M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	368.70M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	296.00M	shares	3 Qtrs
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	373.20M	shares	1 Quarter
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	301.20M	shares	1 Quarter

Cash Flow Statement 60 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$10.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.40M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$222.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$231.10M	USD	3 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$12.60M	USD	3 Qtrs
Change in deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$14.90M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$36.70M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$20.20M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$102.50M	USD	3 Qtrs
Asset impairment charges	`AssetImpairmentChargesIncludingInventoryWriteDown`	$24.70M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$267.00M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$83.40M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$-20.00M	USD	3 Qtrs
Other non-cash operating activities, net	`OtherOperatingActivitiesCashFlowStatement`	$3.50M	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$97.80M	USD	3 Qtrs
Net Cash Provided by Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$347.80M	USD	3 Qtrs
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$74.30M	USD	3 Qtrs
Net purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$86.00M	USD	3 Qtrs
Cash paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	3 Qtrs
Cash paid for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$32.80M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.60M	USD	3 Qtrs
Other investing activities, net	`PaymentsForProceedsFromOtherInvestingActivities`	$41.70M	USD	3 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-160.50M	USD	3 Qtrs
Net Cash Used for Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-78.90M	USD	3 Qtrs
Repayments of borrowings (Note 9)	`RepaymentsOfLongTermLinesOfCredit`	-	USD	3 Qtrs
Repayments of borrowings (Note 9)	`RepaymentsOfLongTermLinesOfCredit`	$115.00M	USD	3 Qtrs
Proceeds from issuance of long-term debt (Note 9)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	3 Qtrs
Proceeds from issuance of long-term debt (Note 9)	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$2.48B	USD	3 Qtrs
Proceeds from issuance of common stock (Note 1)	`ProceedsFromIssuanceOfCommonStock`	$1.66B	USD	3 Qtrs
Proceeds from issuance of common stock (Note 1)	`ProceedsFromIssuanceOfCommonStock`	-	USD	3 Qtrs
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$191.60M	USD	3 Qtrs
Consideration paid to Lilly in connection with the Separation (Note 1)	`PaymentsOfSeparationRelatedCostsFinancingActivities`	$3.56B	USD	3 Qtrs
Other net financing transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$-247.40M	USD	3 Qtrs
Other net financing transactions with Lilly	`ProceedsFromPaymentsToTransactionsWithParent`	$6.30M	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.70M	USD	3 Qtrs
Other financing activities, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.70M	USD	3 Qtrs
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$327.20M	USD	3 Qtrs
Net Cash Provided by (Used for) Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$-298.60M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.10M	USD	3 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.40M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-357.20M	USD	3 Qtrs
Net increase (decrease) in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$611.50M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$934.90M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$323.40M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.30M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$677.50M	USD	Point-in-time

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period	`StockholdersEquity`	$5.14B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.27B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.58B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.49B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquity`	$7.90B	USD	Point-in-time
Net income	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$10.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.40M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$118.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-222.90M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$35.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-30.30M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.20M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$94.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-37.70M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-116.80M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-40.30M	USD	1 Quarter
Transfers (to)/from Lilly, net	`StockholdersEquityTransfersToFromParent`	$-69.20M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$-3.00M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$58.30M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$-7.00M	USD	1 Quarter
Separation activities	`StockholdersEquitySeparationAdjustments`	$-18.40M	USD	1 Quarter
Issuance of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.66B	USD	1 Quarter
Consideration to Lilly in connection with the Separation	`StockholdersEquityConsiderationToParentInSeparation`	$-4.19B	USD	1 Quarter
Reclassification of net parent company investment	`ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent`	-	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.30M	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.40M	USD	1 Quarter
Stock compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$11.30M	USD	1 Quarter
Other	`StockholdersEquityOther`	$-1.90M	USD	1 Quarter
Balance at end of period	`StockholdersEquity`	$5.14B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.27B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.58B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.49B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.78B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$5.20B	USD	Point-in-time
Balance at end of period	`StockholdersEquity`	$7.90B	USD	Point-in-time

Comprehensive Income 28 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$-62.80M	USD	1 Quarter
Net income	`NetIncomeLoss`	$60.20M	USD	1 Quarter
Net income	`NetIncomeLoss`	$31.50M	USD	1 Quarter
Net income	`NetIncomeLoss`	$70.10M	USD	3 Qtrs
Net income	`NetIncomeLoss`	$10.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$72.70M	USD	1 Quarter
Net income	`NetIncomeLoss`	$35.90M	USD	1 Quarter
Net income	`NetIncomeLoss`	$77.40M	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-53.70M	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-58.90M	USD	1 Quarter
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-20.60M	USD	3 Qtrs
Foreign currency translation	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$85.10M	USD	1 Quarter
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-23.40M	USD	3 Qtrs
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-10.80M	USD	3 Qtrs
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-9.40M	USD	1 Quarter
Defined benefit pension and retiree health benefit plans, net of taxes	`OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax`	$-21.20M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$118.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-222.90M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$35.60M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-30.30M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-9.80M	USD	3 Qtrs
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-28.20M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$94.50M	USD	1 Quarter
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-37.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$60.30M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$47.10M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-27.70M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$154.70M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.